January 30, 2026
AstraZeneca Pays $1.2B Upfront in $18.5B Deal for CSPC’s Long-Acting Obesity Drugs
AstraZeneca; CSPC; obesity drugs; weight loss; licensing deal; China; GLP1RA
Sanofi Discontinues mRNA Seasonal Flu Vaccine Development, Focuses on Existing Vaccines Amid CEO Confidence
Sanofi; mRNA flu vaccine; seasonal flu; vaccine discontinuation; Paul Hudson; Fluzone; Flublok
Lilly Invests $85M Upfront in Repertoire Immune Medicines for Autoimmune Therapies Partnership
Eli Lilly; Repertoire Immune Medicines; autoimmune diseases; DECODE platform; tolerizing therapies; $85M upfront; $1.84B milestones; Flagship Pioneering
AstraZeneca Announces $15 Billion Investment in China Through 2030
AstraZeneca; China; $15B investment; drug R&D; cell therapy; manufacturing; Keir Starmer
TECregen Appoints Dr. Klaas P. Zuideveld as CEO to Lead Thymus Regeneration Platform
TECregen; Klaas Zuideveld; CEO appointment; thymus regeneration; biotechnology; seed financing
Friday Five: Sanofi and Roche Face Headwinds Amid US Pricing Pressures and 2026 Drug Pipeline Shifts
Sanofi; Roche; vaccines; weight loss drugs; US pricing pressures; 2026 outlook
Luma Health Welcomes Michael Chou as SVP of Product to Accelerate Operational AI Development
Luma Health; Michael Chou; SVP of Product; AI platform; healthcare operations
The Lancet Publishes TRICORDER Study: AI-Enabled Stethoscopes Boost Cardiac Detection in NHS Trial
AI stethoscope; TRICORDER study; heart failure; atrial fibrillation; valve disease; NHS trial; The Lancet
Reperio Health and Amazon One Medical Partner to Streamline At-Home Preventive Care
Amazon One Medical; Reperio Health; preventive care; at-home screening; primary care; partnership